Here, we investigate some of the main trends and challenges in peptide bioanalysis such as non-specific binding, and look at how they can be circumvented.

The Sustainable Healthcare Coalition (SHC) emphasises the importance of collaboration with industry to address climate change in healthcare.

A program to reduce the waste of medicines and waste from medicines, centred around six pillars for sustainable pharma.

John Lopez of Novartis discusses the more sustainable possibilities refractive index monitoring offers in SPPS and SPOS.

Key opinion leaders discuss techniques for peptide characterisation and the challenges posed by increasing regulatory requirements.

Novo Nordisk has implemented recombinant peptide production techniques with chemical and enzymatic transformations to reduce its carbon footprint in insulin production, as explained by Thomas Høeg-Jensen, Scientific Director at Novo Nordisk.

Are plant-derived peptides set to replace animal proteins as the go-to supplement for muscle conditioning?

The peptide market is continually developing, but how are manufacturers responding to its new requirements and altering the landscape of peptide manufacturing?

Competition between cosmetic treatments begins.